Letter: risk of inflammatory bowel disease is related to alcohol consumption as well as ACEIs and ARBs-authors' reply

被引：0
|
作者：
Khalili, Hamed [1 ]
Casey, Kevin [2 ]
机构：
[1] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 55卷 / 07期
关键词：
D O I：
10.1111/apt.16842
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：884 / 884
页数：1
相关论文
共 50 条
  • [1] Letter: risk of inflammatory bowel disease is related to alcohol consumption as well as ACEIs and ARBs
    Yin, Jian-Quan
    Wang, Bin-Qiao
    Chen, Zhi-Bo
    He, Hai-Dong
    Huang, Si-Si
    Wang, Wei-Kan
    Wu, Jie
    Fu, Yang-Hua
    Wang, Yong-Lin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (07) : 882 - 883
  • [2] Letter: comedication use and dementia risk in patients with inflammatory bowel disease-authors' reply
    Ronnow Sand, Jakob
    Troelsen, Frederikke Schonfeldt
    Horvath-Puho, Erzsebet
    Henderson, Victor W.
    Sorensen, Henrik Toft
    Erichsen, Rune
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (10) : 1505 - 1506
  • [3] Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply
    Malham, Mikkel
    Jakobsen, Christian
    Paerregaard, Anders
    Hald, Mette
    Virta, Lauri
    Kolho, Kaija-Leena
    Wewer, Vibeke
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1214 - 1215
  • [4] Letter: diagnostic delay in inflammatory bowel disease-Authors' reply
    Pollok, Richard
    Baillie, Samantha
    Jayasooriya, Nishani
    Blackwell, Jonathan
    Petersen, Irene
    Bottle, Alex
    Saxena, Sonia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1205 - 1206
  • [5] Letter: pancreatic involvement in inflammatory bowel disease-authors' reply
    Massironi, Sara
    Vigano, Chiara
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 371 - 371
  • [6] Letter: dermatological complications with therapy for inflammatory bowel disease authors' reply
    Ghosh, S.
    Moran, G. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (02) : 233 - 234
  • [7] Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply
    Chapman, Thomas P.
    Frias Gomes, Catarina
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1621 - 1621
  • [8] Letter: risk factors and impacts of psychological morbidity in young people with inflammatory bowel disease - authors' reply
    Brooks, A. J.
    Rowse, G.
    Ryder, A.
    Peach, E. J.
    Corfe, B. M.
    Lobo, A. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (04) : 426 - 426
  • [9] Letter: causes of fatigue in inflammatory bowel disease remain uncertain - authors' reply
    Artom, M.
    Czuber-Dochan, W.
    Norton, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 763 - 764
  • [10] Letter: screening for adrenal suppression in paediatric inflammatory bowel disease - authors' reply
    Philpott, Hamish
    Dougherty, Michael K.
    Dellon, Evan S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (08) : 885 - 886
12345